✦ LIBER ✦

Oral V2 receptor antagonist (RWJ-351647) in patients with cirrhosis and ascites: a randomized, double-blind, placebo-controlled, single ascending dose study

✍ Scribed by P. J. THULUVATH; A. MAHESHWARI; F. WONG; H. W. YOO; R. W. SCHRIER; C. PARIKH; S. STEARE; J. KORULA

Book ID: 108604725
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 695 KB
Volume: 24
Category: Article
ISSN: 0269-2813
DOI: 10.1111/j.1365-2036.2006.03088.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical trial: short-term effects of co

Clinical trial: short-term effects of combination of satavaptan, a selective vasopressin V2 receptor antagonist, and diuretics on ascites in patients with cirrhosis without hyponatraemia – a randomized, double-blind, placebo-controlled study

✍ P. GINÈS; F. WONG; H. WATSON; R. TERG; R. BRUHA; J.-P. ZARSKI; F. DUDLEY; FOR TH 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled clinical study of the histamine H2-receptor antagonist famotidine in Japanese patients with nonerosive reflux disease

✍ Michio Hongo; Yoshikazu Kinoshita; Ken Haruma 📂 Article 📅 2008 🏛 Springer Japan 🌐 English ⚖ 285 KB

A multicenter, double-blind, dose-rangin

A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: Radiologic progression and correlation of genant and larsen scores

✍ Yebin Jiang; Harry K. Genant; Iain Watt; Mark Cobby; Barry Bresnihan; Roger Aitc 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 3 views

MLN3897 plus methotrexate in patients wi

MLN3897 plus methotrexate in patients with rheumatoid arthritis: Safety, efficacy, pharmacokinetics, and pharmacodynamics of an oral CCR1 antagonist in a phase IIa, double-blind, placebo-controlled, randomized, proof-of-concept study

✍ Clarissa E. Vergunst; Danielle M. Gerlag; Lisa von Moltke; Michael Karol; Tim Wy 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB 👁 3 views

## Abstract ## Objective To assess the efficacy, safety, pharmacokinetics, and pharmacodynamics of the CC chemokine receptor CCR1 antagonist MLN3897 in patients with rheumatoid arthritis (RA) receiving methotrexate (MTX). ## Methods In this phase IIa, proof‐of‐concept study, patients meeting the

Efficacy and tolerability of a selective

Efficacy and tolerability of a selective α2C-adrenergic receptor blocker in recovery from cold-induced vasospasm in scleroderma patients: A single-center, double-blind, placebo-controlled, randomized crossover study

✍ Robert A. Wise; Fredrick M. Wigley; Barbara White; Gwen Leatherman; Jianhua Zhon 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 1 views

## Abstract ## Objective OPC‐28326 is a selective α‐adrenergic antagonist with preferential binding to the α~2C~‐adrenergic receptor (α~2C~‐AR) subtype. This study observed the effect of OPC‐28326 on skin temperature and digital blood flow following an acute cold challenge in patients with Raynaud